Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Quick Check In and Question

Again, the question is not so much what PTSC's revenue recognition policy is, rather what is PDS's revenue recognition policy? We only report our share of their income on one line: equity earnings, and equity earnings are driven by PDS's revenue and expenses.

So I have posed the question days ago, and still wait for an answer.

Best

Share
New Message
Please login to post a reply